[go: up one dir, main page]

NO20083760L - Nye formuleringer - Google Patents

Nye formuleringer

Info

Publication number
NO20083760L
NO20083760L NO20083760A NO20083760A NO20083760L NO 20083760 L NO20083760 L NO 20083760L NO 20083760 A NO20083760 A NO 20083760A NO 20083760 A NO20083760 A NO 20083760A NO 20083760 L NO20083760 L NO 20083760L
Authority
NO
Norway
Prior art keywords
formulations
new formulations
interdose
fpf
therapy
Prior art date
Application number
NO20083760A
Other languages
English (en)
Inventor
John Cappecchi
James Stefely
Trevor Riley
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38523271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20083760(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of NO20083760L publication Critical patent/NO20083760L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår nye farmasøytisk aerosol-formuleringer, fremgangsmåter for fremstilling av disse, anvendelse av dem i terapi, doserteinhalatorer som inneholder de nevnte formuleringer, og anvendelse av bioforenlige polymerer for å redusere variasjon av interdose og/eller for å forbedre finpartikkel-fraksjonen (FPF) av de nevnte formuleringer.
NO20083760A 2006-03-22 2008-09-01 Nye formuleringer NO20083760L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78463406P 2006-03-22 2006-03-22
PCT/US2007/064462 WO2007109698A2 (en) 2006-03-22 2007-03-21 Novel formulations

Publications (1)

Publication Number Publication Date
NO20083760L true NO20083760L (no) 2008-12-17

Family

ID=38523271

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083760A NO20083760L (no) 2006-03-22 2008-09-01 Nye formuleringer

Country Status (18)

Country Link
EP (1) EP2012797A2 (no)
JP (1) JP2009530419A (no)
KR (1) KR20080110854A (no)
CN (1) CN101415428A (no)
AR (1) AR060039A1 (no)
AU (1) AU2007226899A1 (no)
BR (1) BRPI0708798A2 (no)
CA (1) CA2646236A1 (no)
CR (1) CR10261A (no)
EA (1) EA200801854A1 (no)
IL (1) IL193723A0 (no)
MA (1) MA30328B1 (no)
MX (1) MX2008011967A (no)
NO (1) NO20083760L (no)
PE (1) PE20080124A1 (no)
TW (1) TW200803870A (no)
WO (1) WO2007109698A2 (no)
ZA (1) ZA200807682B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2400950T (lt) 2009-02-26 2019-08-26 Glaxo Group Limited Farmacinės kompozicijos, apimančios 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzil)oksi]etoksi}heksil)amino]-1-hidroksetil}-2-(hidroksimetil)fenolį
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69413955T2 (de) * 1993-03-17 1999-04-01 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzung enthaltend einen aus ester-, amid- oder merkaptoester- derivat dispergiermittel
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
ES2317922T3 (es) * 2000-08-05 2009-05-01 Glaxo Group Limited Derivados de beta-carbotioato 17, alfa-acrilcarboniloxiloxi androstano como agentes antiinflamatorios.

Also Published As

Publication number Publication date
AU2007226899A1 (en) 2007-09-27
CR10261A (es) 2008-11-26
EP2012797A2 (en) 2009-01-14
MX2008011967A (es) 2009-01-14
WO2007109698A2 (en) 2007-09-27
MA30328B1 (fr) 2009-04-01
TW200803870A (en) 2008-01-16
JP2009530419A (ja) 2009-08-27
IL193723A0 (en) 2009-08-03
PE20080124A1 (es) 2008-04-21
BRPI0708798A2 (pt) 2011-06-14
ZA200807682B (en) 2009-11-25
CA2646236A1 (en) 2007-09-27
AR060039A1 (es) 2008-05-21
WO2007109698A3 (en) 2008-12-18
EA200801854A1 (ru) 2009-04-28
CN101415428A (zh) 2009-04-22
KR20080110854A (ko) 2008-12-19

Similar Documents

Publication Publication Date Title
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
WO2012142511A3 (en) Orthomolecular compositions and their use in stabilizing the extracellular matrix
MY150285A (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
WO2009135190A3 (en) Therapeutic calcium phosphate particles and methods of making and using same
PH12018500639A1 (en) Optimized monoclonal antibodies agaist tissue factor pathway inhibitor (tfpi)
EP4327867A3 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
MY161088A (en) Agonists of gpr40
NO20065936L (no) Sulfonyletylfosfordiamidater for anvendelse ved behandling av cancer.
MY147994A (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
MX2009014235A (es) 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso.
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof
BR112014008609A2 (pt) composição farmacêutica, recipiente vedado, inalador de dosagem medida, método para o tratamento de um paciente que sofre ou provavelmente sofre de um distúrbio respiratório, e, método para fabricação de uma composição farmacêutica
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
UA107550C2 (uk) Похідні естра-1,3,5(10),16-тетраєн-3-карбоксаміду, способи їх одержання, фармацевтичні препарати, що їх містять, та їх застосування для виготовлення лікарських засобів
BR112014027981A2 (pt) compostos do tipo fumagilol e métodos de produção e utilização dos mesmos
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
NO20092073L (no) Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav
PL2024335T3 (pl) Nowe pochodne imidazolu, ich wytwarzanie i zastosowanie jako leku
UY33219A (es) Cetoenoles cíclicos para terapias
WO2011113000A8 (en) Novel ester containing compositions and methods
MX2015009891A (es) Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion.
NO20083760L (no) Nye formuleringer
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application